As expected, the prognostic benefit of CD127− CD39hi Trm cell infiltration correlated with the abundance of CD8+ T cells, evaluated as CD8A expression, in luminal-like BC tumors (p < 0.0001; Supplementary Fig. 3d). This evidence concerns the gene CD8A and breast cancer.